The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Turmeric : The dried and ground rhizome (the underground stem) of the Curcuma longa plant. It is a bright yellow-orange spice ...

Metformin works by reducing glucose production in the liver and improving insulin sensitivity, whereas Ozempic mimics a natural hormone called GLP-1, which increases insulin release when a person ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Various foods, such as berries, whole grains, fish, milk, and some plant-based options, have shown anti-diabetic effects in studies. These foods are rich in bioactive compounds that may assist in ...

There are at least six kinds of diabetes you should know about. Endocrinologists explain the causes, symptoms, and treatments ...

Scientists have identified a simple blood test that measures insulin resistance which may also help doctors determine which ...